S-1 · primary offering
Issued 2024
Proposed maximum
Shares registered
- Filed
- Effective
Sector: Pharmaceutical PreparationsIndustry: BiotechnologyCountry: USExchange: Nasdaq
DilutionScan read 37 of Upstream Bio, Inc.'s SEC filings and found 1 convertible, 1 ATM program, 1 shelf registration and 1 S-1 registration on file for UPB. The latest dilution event on file is ATM sales on Sep 30, 2026. Analysis updated Nov 15, 2026.
Raise routes on file: active ATM + effective shelf · latest dilution event 48 days ago
The dominant contractual driver and its mechanism, then each further driver ranked.
Sep 30, 2026 · ATM Sale
Every warrant, convertible, ATM and shelf, cited to the filing
A free account reads 3 tickers a day in full
From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)
Shares outstanding, potential dilution and cash over time
Issued 2024
Proposed maximum
Shares registered
Principal
Conversion Price
Issued 2026
Total capacity
Sold to date
Issued 2025
Total capacity
Remaining
Exercise prices, conversion terms, shelf headroom and the filing sentence behind every number.
From $29.99/mo. Signal8 Pro is $49/mo, or $40.67/mo billed yearly ($488/yr)
DilutionScanEvery instrument in full · From $29.99/mo
Covered companies in Biotechnology. All tickers A to Z